Form 4: NeuroOne Medical Technologies Officer Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 252 shares of common stock on February 29, 2024, to satisfy tax obligations.
Summary
- On February 29, 2024, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 252 shares of common stock.
- The transaction was executed at a price of $1.21 per share.
- This disposal was due to the fulfillment of tax obligations.
- Following the transaction, Mertens directly owns 184,163 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock disposal for tax purposes, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of transaction: Steve Mertens disposed of 252 shares of common stock. |
| 03/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.